BNP and NT-proBNP as diagnostic biomarkers for cardiac dysfunction in both clinical and forensic medicine

Z Cao, Y Jia, B Zhu - International journal of molecular sciences, 2019 - mdpi.com
Currently, brain natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) are widely
used as diagnostic biomarkers for heart failure (HF) and cardiac dysfunction in clinical …

Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine

M Weber, C Hamm - Heart, 2006 - heart.bmj.com
In recent years biomarkers have emerged as important tools for diagnosis, risk stratification
and therapeutic decision making in cardiovascular diseases. Cardiac troponins in particular …

High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis

CWL Chin, ASV Shah, DA McAllister… - European heart …, 2014 - academic.oup.com
Aims High-sensitivity cardiac troponin I (cTnI) assays hold promise in detecting the transition
from hypertrophy to heart failure in aortic stenosis. We sought to investigate the mechanism …

Cardiac hormones as diagnostic tools in heart failure

H Ruskoaho - Endocrine reviews, 2003 - academic.oup.com
In patients with heart failure, plasma levels of atrial natriuretic peptide (ANP), B-type
natriuretic peptide (BNP), and the N-terminal fragments of their prohormones (N-ANP and N …

Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) A multicenter study of B-type natriuretic peptide levels, emergency …

A Maisel, JE Hollander, D Guss, P McCullough… - Journal of the American …, 2004 - jacc.org
Objectives: The purpose of this study was to examine the relationships among B-type
natriuretic peptide (BNP) levels within the diagnostic range, perceived congestive heart …

B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea

A Harrison, LK Morrison, P Krishnaswamy… - Annals of emergency …, 2002 - Elsevier
Study Objective: B-Type natriuretic peptide (BNP) is a neurohormone secreted from the
cardiac ventricles in response to volume expansion and pressure overload. We have …

BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in …

MA Silver, A Maisel, CW Yancy… - Congestive heart …, 2004 - Wiley Online Library
Among the most exciting developments in the field of heart failure in recent times has been
the rediscovery of the natriuretic peptide system and its pleuripotent effects on cardiac …

Cardiovascular biomarkers: lessons of the past and prospects for the future

F Omran, I Kyrou, F Osman, VG Lim… - International Journal of …, 2022 - mdpi.com
Cardiovascular diseases (CVDs) are a major healthcare burden on the population
worldwide. Early detection of this disease is important in prevention and treatment to …

Biological variation for N-terminal pro-and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure

AHB Wu, A Smith, S Wieczorek, JF Mather… - The American journal of …, 2003 - Elsevier
Given the limitations of low enrollments, this study suggests that a change of 130% for B-
type natiuretic peptide (BNP) and 90% for N-terminal (NT)-proBNP are necessary before …

Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery

R Hutfless, R Kazanegra, M Madani, MA Bhalla… - Journal of the American …, 2004 - jacc.org
Objectives: The purpose of the present study was to assess whether preoperative and
postoperative B-type natriuretic peptide (BNP) levels could be used as predictors of …